🧬 Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs.

The Biotech Startups Podcast

🧬 Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an Exit From Big Pharma

Listen now

Description

Part 2 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex and challenging drug targets to develop safer and more effective immunotherapies for difficult-to-treat cancers. Rather than leaving drug discovery to chance, iBio guides the process using artificial intelligence, making therapeutic development smarter, faster, and more precise.

More Episodes

See all »

🧬 Grant Aarons - FabricNano - Part 3 | Meeting His Co-Founder at Entrepreneur First | Importance of Sales to the Scientific Community | Disrupting the Petrochemical Industry | The Dark Horse of Biology, Synthetic Biology

Part 3 of 3. My guest for this week’s episode is Grant Aarons, Co-Founder and CEO of FabricNano, a London-based biotech whose mission is to transform industrial chemical processes using cell-free biomanufacturing. FabricNano empowers users with the world's most advanced, flexible, and easily...

Published 05/29/24

The Biotech Startups Podcast

Published 05/29/24

🧬 Grant Aarons - FabricNano - Part 2 | The Defensibility of Software Companies | Studying Econometrics at London Business School | Joining Entrepreneur First | Becoming a Biotech Startup CEO & Navigating the Startup Journey

Part 2 of 3. My guest for this week’s episode is Grant Aarons, Co-Founder and CEO of FabricNano, a London-based biotech whose mission is to transform industrial chemical processes using cell-free biomanufacturing. FabricNano empowers users with the world's most advanced, flexible, and easily...

Published 05/22/24